News Overview

Promoter/Promoter Group of Indraprastha Gas Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Karur Vysya Bank Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Spencers Retail Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Newgen Software Technologies Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Seamec Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Business Wire India Insight Partners, Tiger Global, and Advent International lead an $88 Million investment round for blockchain security company CertiK, bringing the company’s valuation to $2 Billion Interest in the company is as a result of increased crypto losses, with over $1 billion USD lost so far in 2022, while 2021 saw $1.3 billion of crypto assets lost over the entire year. Additionally, events […]

Business Wire India I Squared Capital, a leading global infrastructure investment manager, has closed its ISQ Global Infrastructure Fund III at the $15 billion legal cap, exceeding an initial target of $12 billion. Including commitments from I Squared Capital and a dedicated co-investment vehicle, the fund has $15.5 billion in investable capital and received commitments from over 200 institutional investors, including public and private pensions, […]

Punjab & Sind Bank has executed an agreement on 06 April 2022 for sale of its 8% stake in India SME Asset Reconstruction Company in favour of Dhansamridhi Finance. Powered by Capital Market – Live News

Dr. Reddys Laboratories has received the approval of the National Company Law Tribunal (NCLT), Hyderabad Bench for the scheme of amalgamation of Dr Reddys Holdings an entity held by the Promoter Group, which holds 24.83% equity shares of Dr. Reddys Laboratories into the Company. The scheme was approved on 05 April 2022 and the order was uploaded on the NCLT website on 07 April 2022. […]

with effect from 07 April 2022